Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Silvia Peola
Humoral Immune Responses Toward Tumor-Derived Antigens in Previously Untreated Patients With Chronic Lymphocytic Leukemia
Oncotarget
Oncology
Related publications
Profile of Obinutuzumab for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia
OncoTargets and Therapy
Oncology
Pharmacology
Chemoimmunotherapy May Overcome the Adverse Prognostic Significance of 11q Deletion in Previously Untreated Patients With Chronic Lymphocytic Leukemia
Cancer
Cancer Research
Oncology
Phase 1b Study of Venetoclax-Obinutuzumab in Previously Untreated and Relapsed/Refractory Chronic Lymphocytic Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
The Impacts of Zanubrutinib on Immune Cells in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Membrane-Bound Immunoglobulins on Human Leukemic Cells. Evidence for Humoral Immune Responses of Patients to Leukemia-Associated Antigens.
Journal of Clinical Investigation
Medicine
Externally Validated Predictive Clinical Model for Untreated Del(17p13.1) Chronic Lymphocytic Leukemia Patients
American Journal of Hematology
Hematology
Coevolution of Leukemia and Host Immune Cells in Chronic Lymphocytic Leukemia
Cold Spring Harbor perspectives in medicine
Biochemistry
Medicine
Genetics
Molecular Biology
TCL1targetingmiR-3676is Codeleted With Tumor Protein P53 in Chronic Lymphocytic Leukemia
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
